Roberto Nani
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver physiology and pathology
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
-
- Renal cell carcinoma treatment 1
- Radiation Therapy and Dosimetry 1
- Renal and Vascular Pathologies 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Co-authors
- Roberto Cioni (1 shared paper)Matteo Renzulli (1 shared paper)Irene Bargellini (1 shared paper)Franco Trevisani (1 shared paper)Emanuela Giampalma (1 shared paper)G Gandini (1 shared paper)Daniele Gasparini (1 shared paper)Luigi Bolondi (1 shared paper)
- Journals
- International Journal of Technology Management (1 paper)Kidney International (1 paper)British Journal of Cancer (1 paper)Digestive and Liver Disease (1 paper)Future Oncology (1 paper)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Roberto Nani
13 papers receiving 655 citations
Roberto Nani's Hit Papers
Peers
Comparison fields: 5 of 63
- Hepatology 491
- Epidemiology 139
- Transplantation 11
- Pathology and Forensic Medicine 69
- Pulmonary and Respiratory Medicine 82
Countries citing papers authored by Roberto Nani
This map shows the geographic impact of Roberto Nani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Nani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Nani more than expected).
Fields of papers citing papers by Roberto Nani
This network shows the impact of papers produced by Roberto Nani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Nani. The network helps show where Roberto Nani may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Nani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma Hit paper breakdown → | 2014 | 438 |
| 2 | 2019 | 38 | |
| 3 | 2010 | 34 | |
| 4 | 2020 | 30 | |
| 5 | 2007 | 30 | |
| 6 | 2001 | 25 | |
| 7 | 2017 | 23 | |
| 8 | 2017 | 14 | |
| 9 | 2023 | 10 | |
| 10 | 2002 | 9 | |
| 11 | 2011 | 6 | |
| 12 | 2018 | 4 | |
| 13 | 2021 | 3 | |
| 14 | 2025 | 0 | |
| 15 | TRIZ-Based Patent Investigation by Evaluating Inventiveness. | 2008 | 0 |
| 16 | 2018 | 0 | |
| 17 | 2017 | 0 | |
| 18 | 2011 | 0 |
About Roberto Nani
Roberto Nani is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Oncology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 664 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Ultrasound and Hyperthermia Applications (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Intellectual Property and Patents (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Renal cell carcinoma treatment (1 paper), Radiation Therapy and Dosimetry (1 paper) and Renal and Vascular Pathologies (1 paper). The work is most often cited by research in Hepatology (491 citations), Epidemiology (139 citations), Transplantation (11 citations), Pathology and Forensic Medicine (69 citations) and Pulmonary and Respiratory Medicine (82 citations). Roberto Nani has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Roberto Cioni, Matteo Renzulli, Irene Bargellini, Franco Trevisani, Emanuela Giampalma, G Gandini, Daniele Gasparini, Luigi Bolondi, Alessandro Cucchetti and Rita Golfieri. Their work appears in journals such as International Journal of Technology Management, Kidney International, British Journal of Cancer, Digestive and Liver Disease and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.